Home » PHARMA-BIOTECH ALLIANCES TO GET RISKIER, SAYS REPORT
PHARMA-BIOTECH ALLIANCES TO GET RISKIER, SAYS REPORT
According to a new report, key trends that are occurring within pharma-biotech alliances, as well as within biotech-biotech alliances, are having to grapple with safety concerns and efficacy, which have made biotech a high-risk area for investment.
BioPharmaReporter.com
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May